|
⚲
|
| Keyboard |
| Fonteyne Paul R
✚
|
|
|---|---|
| CIK # | 0001727550 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001727550] | |
| 4 | [0001727550] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Amylyx Pharmaceuticals Inc | |
| Fonteyne Paul R | |
| Apellis Pharmaceuticals Inc | |
| Covetrus Inc | |
| Gelesis Holdings Inc | |
| AMAG Pharmaceuticals Inc | |
| Adicet Bio Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2026-01-01 | Grant | 14,684 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2026-01-01 | Grant | 7,961 | $0.00 | |
|
Amylyx Pharmaceuticals Inc AMLX
Stock Option (right to buy) · derivative
|
2025-06-05 | Grant | 25,000 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-01-01 | Grant | 6,267 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2025-01-01 | Grant | 11,199 | $0.00 | |
|
Amylyx Pharmaceuticals Inc AMLX
Stock Option (right to buy) · derivative
|
2024-06-06 | Grant | 25,000 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2024-01-01 | Grant | 5,748 | $59.86 | 344,075 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-01-01 | Grant | 3,341 | $0.00 | |
|
Amylyx Pharmaceuticals Inc AMLX
Stock Option (right to buy) · derivative
|
2023-06-08 | Grant | 16,985 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2023-01-01 | Grant | 3,867 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2023-01-01 | Grant | 7,441 | $0.00 | |
|
Covetrus Inc CVET
Restricted Stock Units · derivative
|
2022-10-13 | Disposed to issuer | 14,638 | $0.00 | |
|
Covetrus Inc CVET
Common Stock
|
2022-10-13 | Disposed to issuer | 13,275 | $0.00 | |
|
Covetrus Inc CVET
Common Stock
|
2022-07-01 | Option exercise | 8,275 | $0.00 | |
|
Covetrus Inc CVET
Restricted Stock Units · derivative
|
2022-07-01 | Option exercise | 8,275 | $0.00 | |
|
Amylyx Pharmaceuticals Inc AMLX
Stock Option (Right to Buy) · derivative
|
2022-06-09 | Grant | 19,000 | $0.00 | |
|
Covetrus Inc CVET
Restricted Stock Units · derivative
|
2022-05-11 | Grant | 14,638 | $0.00 | |
|
Gelesis Holdings Inc GLS
Common Stock
|
2022-05-06 | Grant | 53,832 | ||
|
Amylyx Pharmaceuticals Inc AMLX
Stock Option (Right to Buy) · derivative
|
2022-01-06 | Grant | 8,400 | $0.00 | |
|
Amylyx Pharmaceuticals Inc AMLX
Common Stock
|
2022-01-06 | Buy | 3,947 | $19.00 | 74,993 |
| showing 20 of 38 most recent transactions | |||||